Pfizer : PFE

All Pfizer Articles

1508 Articles

Trey Thoelcke | Apr 13, 2020 at 7:05 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Exxon, Microsoft and Pfizer above all other Dow stocks. It…

Chris Lange | Apr 9, 2020 at 10:01 AM EDT

Will the Pfizer-BioNTech Collaboration Be a Winner in the Fight Against COVID-19?

Pfizer and BioNTech each saw gains on Thursday after the companies announced additional details regarding their collaboration in the fight…

Paul Ausick | Mar 31, 2020 at 1:17 PM EDT

Court Rejects Patent Protection, Crushing Amarin Stock

Until late Monday, Amarin continued to get good news relevant to Vascepa, its treatment for cardiovascular disease. The big news,…

Jon C. Ogg | Mar 27, 2020 at 9:08 AM EDT

Top Analyst Upgrades and Downgrades: American Airlines, Chipotle, Ericsson, Microsoft, Mylan, Novavax, Pfizer, P&G, Qualcomm, Square, Starbucks and More

Friday's top analyst upgrades and downgrades included American Airlines, Chipotle Mexican Grill, Ericsson, Microsoft, Mylan, Novavax, Pfizer, Procter & Gamble,…

Chris Lange | Mar 18, 2020 at 9:45 AM EDT

BioNTech’s Coronavirus Vaccine Just Got Strong Backing

BioNTech stock jumped on Tuesday and went even higher early on Wednesday. This comes after the company announced a collaboration…

Chris Lange | Mar 11, 2020 at 9:44 AM EDT

Short Sellers Run for Cover From Big Pharma Stocks

The February 28 short interest data have been compared with the previous figures, and short interest in these top pharmaceutical…

Trey Thoelcke | Mar 11, 2020 at 7:05 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Pfizer, Intel and Exxon above all other Dow stocks.

Jon C. Ogg | Feb 27, 2020 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Cree, Etsy, Gilead, Pfizer, Rite Aid, Solar Edge, Square, 3D Systems, Virgin Galactic and More

Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Cree, Etsy, Gilead Sciences, Pfizer, Rite Aid, Solar Edge, Square,…

Chris Lange | Feb 27, 2020 at 8:45 AM EST

Big Pharma Scares Off Short Sellers

The February 14 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Feb 27, 2020 at 7:00 AM EST

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Pfizer, Microsoft and Intel above all other Dow stocks.

Chris Lange | Feb 12, 2020 at 9:50 AM EST

Big Pharma Sees a Rising Tide in Short Interest

The January 31 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Feb 12, 2020 at 6:55 AM EST

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Pfizer, Microsoft and Intel above all other Dow stocks.

Jon C. Ogg | Feb 6, 2020 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Boeing, Etsy, Gilead Sciences, GoPro, Micron Technology, Newmont, Peloton Interactive,…

Jon C. Ogg | Feb 5, 2020 at 1:20 PM EST

Merck’s Spin-Off May Create Operational Risks for the Year Ahead

Merck finds itself in a position of being an acquirer of sorts at the same time it wants to spin…

Chris Lange | Jan 28, 2020 at 10:40 AM EST

How Far Will Pfizer Stock Slump?

Pfizer stock retreated after it released a disappointing fourth-quarter earnings report before the opening bell Tuesday.

1 … 24 25 26 27 28 … 101

Pfizer : PFE

All Pfizer Articles

The 5 Most Shorted Dow Stocks

Will the Pfizer-BioNTech Collaboration Be a Winner in the Fight Against COVID-19?

Court Rejects Patent Protection, Crushing Amarin Stock

Top Analyst Upgrades and Downgrades: American Airlines, Chipotle, Ericsson, Microsoft, Mylan, Novavax, Pfizer, P&G, Qualcomm, Square, Starbucks and More

BioNTech’s Coronavirus Vaccine Just Got Strong Backing

Short Sellers Run for Cover From Big Pharma Stocks

The 5 Most Shorted Dow Stocks

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Cree, Etsy, Gilead, Pfizer, Rite Aid, Solar Edge, Square, 3D Systems, Virgin Galactic and More

Big Pharma Scares Off Short Sellers

The 5 Most Shorted Dow Stocks

Big Pharma Sees a Rising Tide in Short Interest

The 5 Most Shorted Dow Stocks

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

Merck’s Spin-Off May Create Operational Risks for the Year Ahead

How Far Will Pfizer Stock Slump?

The $111,000 Tax-Free Giving Strategy Retirees Are Missing in 2026

VOO Just Crossed $1 Trillion. Here’s the Hidden Risk Nobody’s Pricing In

Why the Pure Bitcoin-Miner Fund Crushed the Blockchain Basket, Up 184%

The $111,000 Tax-Free Giving Strategy Retirees Are Missing in 2026

Why Age 63 Is the Most Expensive Year to Touch Your IRA (Medicare Looks Back Two Years)

The $111,000 Tax-Free Giving Strategy Retirees Are Missing in 2026

VOO Just Crossed $1 Trillion. Here’s the Hidden Risk Nobody’s Pricing In

Pfizer : PFE

All Pfizer Articles

The 5 Most Shorted Dow Stocks

Will the Pfizer-BioNTech Collaboration Be a Winner in the Fight Against COVID-19?

Court Rejects Patent Protection, Crushing Amarin Stock

Top Analyst Upgrades and Downgrades: American Airlines, Chipotle, Ericsson, Microsoft, Mylan, Novavax, Pfizer, P&G, Qualcomm, Square, Starbucks and More

BioNTech’s Coronavirus Vaccine Just Got Strong Backing

Short Sellers Run for Cover From Big Pharma Stocks

The 5 Most Shorted Dow Stocks

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Cree, Etsy, Gilead, Pfizer, Rite Aid, Solar Edge, Square, 3D Systems, Virgin Galactic and More

Big Pharma Scares Off Short Sellers

The 5 Most Shorted Dow Stocks

Big Pharma Sees a Rising Tide in Short Interest

The 5 Most Shorted Dow Stocks

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

Merck’s Spin-Off May Create Operational Risks for the Year Ahead

How Far Will Pfizer Stock Slump?

The $111,000 Tax-Free Giving Strategy Retirees Are Missing in 2026

VOO Just Crossed $1 Trillion. Here’s the Hidden Risk Nobody’s Pricing In

Why the Pure Bitcoin-Miner Fund Crushed the Blockchain Basket, Up 184%

Featured Reads

The $111,000 Tax-Free Giving Strategy Retirees Are Missing in 2026

Why Age 63 Is the Most Expensive Year to Touch Your IRA (Medicare Looks Back Two Years)